Electroacupuncture Therapy for Tumors – A New Approach
Modern acupuncture increasingly integrates modern technologies such as electricity, sound, light, heat, and magnetism with traditional acupuncture theories and techniques, leading to the development of new acupuncture devices that expand the scope and enhance the efficacy of acupuncture treatments. In global healthcare, traditional acupuncture will play an increasingly important role.
Electroacupuncture involves inserting fine needles into acupoints ("de qi" sensation achieved), then applying a low-intensity electrical current close to human bioelectricity to treat diseases. By combining needle stimulation with electrical stimulation, electroacupuncture enhances therapeutic effects. While traditionally applied to various conditions, its applications have expanded recently—including tumor treatment.
Tumor therapy remains a major challenge in modern medicine, particularly malignant tumors, which often seem incurable. However, electroacupuncture, developed based on traditional Chinese acupuncture theory, has been systematically researched over ten years, establishing standardized protocols regarding methodology, theory, and indications, proving its significant efficacy in treating tumors.
Electroacupuncture for tumors was pioneered by Professor Xin, a thoracic surgery expert at China-Japan Friendship Hospital, based on clinical experience, integrating traditional Chinese acupuncture principles with insights from Swedish scientists’ electrotherapy for tumors. After years of exploration, it evolved into a novel therapy for both malignant and benign tumors.
Historically, tumors were treated by heating needles and inserting them directly into the tumor site to relieve pain and break up stasis. However, fire needle therapy kills cells only within about 2 mm around the needle tip, with heat dissipating quickly and unable to spread further—making it impractical. Modern electroacupuncture replaces heat with direct current, which can dissociate and destroy cancer cells. Moreover, the affected area spreads up to ten times wider than heat-based methods—covering nearly half an inch (over 1 cm)—so for a 5 cm tumor, only four to five needles are needed.
This new electroacupuncture therapy directly targets and destroys cancer cells without damaging organ functions. Compared to conventional medical approaches, it offers advantages such as safety, high efficacy, fewer complications, minimal trauma, and rapid recovery. It proves highly effective for patients with recurrent postoperative tumors, those unresponsive to radiotherapy or chemotherapy, tumors located in facial areas unsuitable for surgery, and elderly or frail patients who cannot withstand surgery. In some cases, it achieves results comparable to surgical removal. For example, cavernous hemangiomas are notoriously difficult to treat—previous surgical excision often leads to uncontrollable bleeding. Electroacupuncture can occlude blood vessels within the hemangioma one by one, greatly improving safety. In cases where surgery would require extensive skin loss or amputation, patients often refuse. Electroacupuncture enables local cure in such situations. For patients whose heart or lung function precludes major surgery, electroacupuncture can serve as an alternative: locally treat the tumor, then combine with radiotherapy, chemotherapy, immunotherapy, and traditional Chinese medicine for comprehensive treatment—achieving outcomes equivalent to surgery, radiotherapy, and chemotherapy.
Electroacupuncture not only demonstrates remarkable efficacy but also features simple, easy-to-learn techniques, contributing to widespread adoption. Over 2,000 physicians have received training, and more than 1,000 hospitals nationwide now use this technology. To date, approximately 8,000 tumor patients in China have undergone electroacupuncture treatment, achieving a total effective rate exceeding 70%
Indications for electroacupuncture therapy:
Facial and head tumors, breast cancer, parotid cancer, nasopharyngeal cancer, oral cancer, tongue cancer, cutaneous lymph node cancer, malignant melanoma, rhabdomyosarcoma, cervical cancer, rectal cancer, penile cancer, lung cancer, liver cancer, laryngeal cancer, adrenal cancer, esophageal cancer, nasopharyngeal cancer, etc.